EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 81 filers reported holding EIDOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,685,000 | +123.9% | 20,406 | -13.9% | 0.00% | – |
| Q3 2020 | $1,199,000 | +15.1% | 23,712 | +8.5% | 0.00% | – |
| Q2 2020 | $1,042,000 | +19.6% | 21,847 | +23.0% | 0.00% | – |
| Q1 2020 | $871,000 | +20.8% | 17,756 | +41.4% | 0.00% | – |
| Q4 2019 | $721,000 | +213.5% | 12,560 | +96.8% | 0.00% | – |
| Q3 2019 | $230,000 | +17.3% | 6,382 | +0.9% | 0.00% | – |
| Q2 2019 | $196,000 | -12.9% | 6,323 | -34.3% | 0.00% | – |
| Q1 2019 | $225,000 | +281.4% | 9,623 | +123.6% | 0.00% | – |
| Q4 2018 | $59,000 | +490.0% | 4,304 | +319.5% | 0.00% | – |
| Q3 2018 | $10,000 | – | 1,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |